NCT06234761View on ClinicalTrials.gov

Immunological Mechanisms Underlying Mucosal IgE Responses

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Pathophysiology
Interventions
DRUG

Dupilumab

Patient who start to take dupilumab will be followed. This study is only observational

Trial Locations (1)

9000

RECRUITING

University Hospital Gent, Ghent

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University Hospital, Ghent

OTHER

NCT06234761 - Immunological Mechanisms Underlying Mucosal IgE Responses | Biotech Hunter | Biotech Hunter